The House Ways & Means Committee’s markup of a closely watched health bill Wednesday (July 26) was laden with partisan frustration after Democrats accused Republicans of failing to extend price transparency requirements to Medicare Advantage and prescription drug plans, or to build up additional oversight of private equity in health care. The Health Care Price Transparency Act passed Wednesday 25-16 along party lines. The wide-ranging bill would establish certain site-neutral payments in Medicare for hospital outpatient departments located separately from...